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INTRODUCTION
The use of saliva as a diagnostic fluid has been in-
creasingly reported worldwide in the last decade. 
Technological advancement has taken place during 
the past few years enabling the use of saliva as a 
clinical specimen to diagnose disease and predict 
disease progression (1).
Initially, saliva was used as a clinical specimen for 
antibody detection in the diagnosis of infectious 
diseases. Detection of salivary antibody was found 
to be useful for the diagnosis of bacterial infections 
caused by Helicobacter pylori, Shigella, and Borrelia 
burgdorferi (2-4) and various viral infections, such 
as hepatitis A, hepatitis B, hepatitis C, measles, 
mumps, rubella, rotavirus, dengue, parvovirus B 
19, and HIV (5-11). Detection of salivary antibody 
has also been studied for the diagnosis of some 
parasitic infections caused by Toxoplasma gondii, 
Schistosoma mansoni, Taenia solium, and Entamoeba 
histolytica (12-15).
Subsequently, saliva has also been used for the 
detection of antigen in the diagnosis of pneumo-
coccal pneumonia (16), hepatitis B virus, measles, 
mumps, and rubella (17-20). There is only one re-
port till date on the detection of salivary lectin an-
tigen of E. histolytica for the diagnosis of amoebic 
liver abscess (ALA) with a sensitivity and specificity 
of 22% and 97.4% respectively (21).   
The reports on the use of saliva for the detection of 
DNA for the diagnosis of infectious diseases, how-
ever, are limited (22-26). The polymerase chain re-
action (PCR) has been used for facilitating diagnosis 
of viral infections, such as Epstein-Barr, cytomega-
lovirus, human herpes virus 6, 7, and 8, and rabies 
using saliva (22-25). The PCR has also been evalu-
ated for the detection of H. pylori-associated peptic 
ulcer, by demonstration of H. pylori DNA in saliva 
(26). However, reports on the detection of DNA 
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in saliva of patients with parasitic infection, even 
amoebiasis, is still lacking. In the present study, we, 
therefore, made an attempt to detect E. histolytica 
DNA, possibly released in the saliva of ALA patients 
by applying a 16S-like rRNA gene-based nested 
multiplex PCR (NM-PCR) assay. ALA is a condition 
which is the most important and serious extra-in-
testinal manifestation of amoebiasis, which is asso-
ciated with high morbidity and mortality. An early 
and specific diagnosis of the condition followed by 
immediate treatment reduces morbidity and mor-
tality due to the disease to a great extent.
MATERIALS AND METHODS
Sample details
The present study was conducted in the Jawahar-
lal Institute of Postgraduate Medical Education and 
Research (JIPMER) Hospital, Puducherry, India, 
during August 2005–March 2006. 
Patients with ALA (n=28): The study included 
28 ALA patients; diagnosis was done on the basis 
of radiological, symptomatological and laboratory 
criteria (27,28), such as: (a) ultrasonography reveal-
ing a space-occupying lesion in the liver suggestive 
of an abscess; (b) clinical symptoms, such as pain 
in the right hypochondrium, lower chest, back, or 
tip of the right shoulder, and fever; (c) distended 
and/or tender liver, generally without jaundice; (d) 
chest radiograph showing raised right dome of the 
diaphragm; (e) treatment with anti-amoebic drugs, 
e.g. metronidazole, results in improvement of the 
condition; (f) positive indirect haemagglutination 
(IHA) of serum antibody showing a titre (≥1:128) 
against E. histolytica; and (g) liver aspirate appeared 
like anchovy sauce but was bacteriologically sterile. 
In the present study, the 28 ALA patients included 
eight patients on whom the metronidazole thera-
py was not initiated and 20 patients on whom the 
metronidazole therapy was already initiated.
Patients with pyogenic liver abscess (PLA) and 
other diseases of the liver (n=21): The study in-
cluded cases of PLA (n=13), hydatid cyst in liver 
(n=2), liver hepatoma (n=1), liver cirrhosis (n=3), 
and viral hepatitis (n=2).
Healthy control (n=35): The study included 35 
healthy controls who had no history of recent dys-
entery or diarrhoea and whose stool samples were 
negative for E. histolytica-associated infection by 
microscopy and culture. 
Sample collection
Saliva: Saliva specimens were collected from all the 
28 ALA patients, 21 patients with PLA and other 
diseases of the liver, and 35 healthy controls. 5 mL 
of saliva specimen was collected from each indi-
vidual in a sterile container using the aseptic tech-
niques and was stored at 4 °C until used.
Liver abscess pus: The aspiration of liver abscess 
pus was indicated only under the following con-
ditions (27): (a) to rule out a pyogenic abscess; (b) 
the failure to respond clinically in 3-5 days; (c) the 
threat of imminent rupture; and (d) the prevention 
of rupture of left-lobe abscess into the pericardium. 
The liver abscess pus aspirates were performed, 
only for clinical purposes as judged by the clini-
cians for the patient care and not for the purpose 
of this study. Liver abscess pus was obtained under 
ultrasound guidance from all the 28 ALA patients 
and 13 PLA patients and was stored at -20 °C in a 
sterile container until used.
Blood: Blood specimens were collected from all the 
28 ALA patients, 21 with PLA and other diseases of 
the liver, and 35 healthy controls. 5 mL of venous 
blood was collected in a sterile container; sera were 
separated and stored at -20 °C until used. 
Detection of anti-amoebic antibodies in 
serum by IHA 
The Rapid-IHA was performed on serum specimen 
as per the method described earlier (29). A titre of 
≥1:128 was considered to be positive for ALA (30).
Detection of Gal/GalNAc lectin antigen in 
liver pus by TechLab E. histolytica II ELISA 
The TechLab E. histolytica II test was performed on 
liver abscess pus specimens to detect E. histolytica-
specific Gal/GalNAc lectin antigen as per the meth-
od described earlier (28).
NM-PCR 
Extraction of Entamoeba genomic DNA from 
saliva and liver abscess pus
The protocol for extraction of DNA from saliva 
and liver abscess pus specimen has been modified 
in our laboratory from cetyltrimethylammonium 
bromide (CTAB) DNA extraction protocol origi-
nally described for DNA extraction from amoebic 
culture (31).
Saliva: Briefly, 5 mL of saliva was centrifuged at 
12,000 g for eight minutes at 4 °C. The supernatant Khairnar K et al. Detection of salivary Entamoeba histolytica DNA
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was discarded, and the pellet was suspended in 250 
µL of sterile distilled water. To the suspension 5 µL 
of proteinase-K (10 mg/mL) and 40 µL of 10% sodi-
um dodecyl sulphate was added and incubated for 
three hours at 65 °C. Then, 60 µL of 5 M sodium 
chloride and 15 µL of 10% CTAB were added to the 
mixture and incubated for 45 minutes at 65 °C. This 
was followed by extractions with equal volumes of 
chloroform and then phenol-chloroform-isoamyl 
alcohol. The DNA was precipitated with ice-cold 
ethanol. The dried DNA pellet was dissolved in 50 
µL of sterile distilled water.
Liver abscess pus: The extraction of Entamoeba ge-
nomic DNA from liver abscess pus was performed 
as per the method described earlier (32).
The extracted DNA from saliva and liver abscess 
pus sample was passed through DNA clean-up spin 
columns (Bangalore Genei KT-62, Bangalore). The 
DNA was stored at -20 °C until used.
Quantification of DNA in saliva and liver 
abscess pus
DNA quantification in spin column-purified DNA 
extract from saliva and liver abscess pus specimens 
was determined by ultraviolet (UV) absorbance us-
ing a Cintra 5 double beam spectrophotometer. 
DNA yield was calculated on the basis of UV absor-
bance × dilution. The purity of the nucleic acid in 
the samples was estimated by the ratio of readings 
at 260 nm and 280 nm (OD260/OD280).
Primers used
Based on the sequences of the 16S-like rRNA gene of 
E. histolytica, E. dispar, and E. moshkovskii nested 
set of primers (designated E-1/E-2, EH-1/EH-2, ED-1/
ED-2, and Mos-1/Mos-2) were used as previously de-
scribed (32).
In addition, we have used an internal amplification 
control (IAC) targeting human 18S ribosomal RNA 
gene to rule out false-negative results in clinical 
specimens as previously described (32).
Primer validation
The primer sequences for E. moshkovskii, E. histolyti-
ca, E. dispar, and human IAC were subjected to the 
basic local alignment search tool (BLAST) in the ge-
nome database of all organisms available at http://
www.ncbi.nlm.nih.gov/blast/ and were found to 
be specific for the study. The 439 bp PCR products 
of E. histolytica species from representative saliva 
and liver abscess pus specimens were confirmed 
by getting both the strands of DNA sequenced on 
ABI3730XL sequencer (Macrogen, Seoul, South 
Korea). The nucleotide sequencing was done using 
species-specific primers, i.e. EH-1/EH-2, for E. his-
tolytica. The nucleotide sequences were analyzed for 
homology using the nucleotide-nucleotide BLAST 
search feature available at http://www.ncbi.nlm.
nih.gov/blast/. The identities between the nucle-
otide sequencing result of representative 439 bp PCR 
products of E. histolytica species from saliva and liver 
abscess pus specimens with the sequence deposited 
in GenBank [accession number: X56991] were ana-
lyzed using ‘Align two sequences (bl2seq)’ feature 
available at http://www.ncbi.nlm.nih.gov/blast/. 
The multiple sequence alignment of the nucleotide 
sequences of representative 439 bp PCR products 
of E. histolytica species from saliva and liver ab-
scess pus specimens with the sequence deposited 
in GenBank [accession number: X56991] was also 
done using the BioEdit software  (version 7).
Standard strains
Three standard strains—E. histolytica HM-1:IMSS, 
E. dispar SAW760, and E. moshkovskii Laredo—were 
used as positive control in the present study. The 
lyophilized DNA of these strains was generously 
gifted by Dr. C. Graham Clark from the London 
School of Hygiene & Tropical Medicine, UK.
NM-PCR  for saliva and liver abscess pus
Saliva PCR: For a reaction volume of 25 µL, com- For a reaction volume of 25 µL, com-
prising 2.5 µL of 10X PCR buffer (Biogene, Kim- Kim-
bolton, UK), 1.0 µL of 25 mM MgCl2 (Bangalore 
Genei, Bangalore, India), 0.75 µL of deoxy-ribonu-
cleotide triphosphate mix (10 mM each dNTP, Bio-
gene, Kimbolton, UK), 0.3 µL (5 IU/µL) of Taq poly-
merase (Biogene, Kimbolton, UK), 10 picomoles of 
target DNA primers (IDT, Coralville, USA), and 5 pi-  Coralville, USA), and 5 pi- ), and 5 pi-
comoles of IAC primers (IDT, Coralville, USA) were 
added in genus- and species-specific PCR. The tem- The tem-
plate DNA volume was 2 μL for both genus- and 
species-specific PCR. The PCR tubes were finally 
placed in an Eppendorf thermal cycler (master cy-
cler gradient; Westbury, NY, USA).
 The conditions for genus-specific PCR were as fol-
lows; the PCR mix was subjected to an initial de-
naturation at 96 °C for two minutes, followed by 
30 cycles—each consisting of 92 °C for 60 seconds 
(denaturation), 56 °C for 60 seconds (annealing), 
and 72 °C for 90 seconds (extension). Finally, one 
cycle of extension at 72 °C for seven minutes was 
performed. In the species-specific NM-PCR (which 
had multiple primer-sets in the same tube), only Khairnar K et al. Detection of salivary Entamoeba histolytica DNA
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the annealing temperature was changed to 48 °C, 
leaving the other parameters of the amplification 
cycles unchanged.
Liver abscess pus PCR: The PCR mix composition 
and PCR conditions for the amplification of Entamoe-
ba 16S-like rRNA gene from liver abscess pus was per-
formed as per the method described earlier (32).
3.5 µL of the amplification product was separated 
by electrophoresis through 1.8% agarose gel (Aga-
rose Low EEO; Bangalore Genie, Bangalore, India) 
containing ethidium bromide in 0.5 X Tris-borate-
EDTA at 120 V for 45 minutes and was visualized 
under UV light for bands of DNA of appropriate 
sizes (Fig.). 
Analysis of statistical data 
Sensitivity was calculated as the number of patients 
with positive test results/total number of patients 
× 100. Specificity was calculated as the number of 
controls with negative test results divided by total 
number of controls × 100. To calculate the signifi-
cance of the difference in sensitivities, McNemar’s 
chi-square test was applied. The McNemar’s test 
was performed using the Graph Pad Software.
RESULTS
Detection of anti-amoebic antibodies in 
serum by IHA 
The IHA test was positive for anti-amoebic antibo-
dies in the serum of 22 (78.6%) of the 28 ALA pa-
tients and two (5.7%) of 35 healthy controls. The 
IHA test was negative for anti-amoebic antibodies 
in the serum of all 21 patients with PLA and other 
diseases of the liver.
Detection of Gal/GalNAc lectin antigen in liver pus 
by TechLab 
E. histolytica II ELISA 
The TechLab E. histolytica II enzyme-linked im-
munosorbent assay (ELISA) test was positive for E. 
histolytica Gal/GalNAc lectin antigen in the liver ab-
scess pus of 13 (46.4%) of the 28 ALA patients. The 
TechLab E. histolytica II ELISA detected E. histolytica 
lectin antigen in the liver pus of all the eight (100%) 
ALA patients who were tested prior to treatment 
with metronidazole but was detected in only five 
(25%) of the 20 ALA patients who were tested after 
the initiation of therapy with metronidazole. This 
might be due to the rapid clearing of amoebic anti-
gen from the liver pus due to killing of E. histolytica 
trophozoites on treatment with metronidazole. The 
TechLab E. histolytica II ELISA test was negative for 
E. histolytica Gal/GalNAc lectin antigen in the liver 
abscess pus of all the 13 patients with PLA.
NM-PCR 
Quantification of DNA in saliva and liver 
abscess pus 
The average DNA yield for all saliva and liver ab-
scess pus specimens was found to be approximately 
33 and 85 µg/mL respectively by spectrophotomet-
ric analysis. The purity of DNA extract from saliva 
and liver abscess pus specimens was found to be 
satisfactory as the ratio of readings at 260 nm and 
280 nm (OD260/OD280) was approximately 1.8.
Primer validation
The sequencing result of representative 439 bp PCR 
products of E. histolytica species from saliva and liver 
abscess pus specimens showed 99-100% identities 
to the sequence deposited in GenBank [accession 
number: X56991]. The multiple sequence align-
ment of the nucleotide sequences of representative 
439 bp PCR products of E. histolytica species from 
saliva and liver abscess pus specimens with the se-
quence deposited in GenBank [accession number: 
X56991] showed no discrepancy. 
Fig. Results of nested multiplex PCR on repre-
        sentative saliva and liver abscess pus specimen
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NM-PCR  for saliva and liver abscess pus
The NM-PCR performed on the representative sa-
liva specimen is shown in the figure. The NM-PCR 
detected E. histolytica DNA in eight (28.6%) of the 
28 saliva specimens collected from the ALA patients 
(Table). The NM-PCR was negative for E. histolytica 
DNA in the saliva of all the eight ALA patients who 
were tested prior to treatment with metronidazole 
but was positive in the saliva of eight (40%) of the 
20 ALA patients who were tested after therapy 
with metronidazole. The NM-PCR was negative for 
E. histolytica DNA in the saliva of all the 21 patients 
with PLA and other diseases of the liver and 35 
healthy controls (Table). In this study, the prob-
ability of negative NM-PCR results in the saliva 
specimens due to PCR inhibitors was ruled out by 
the inclusion of an IAC in the PCR reaction. 
The result of NM-PCR performed on the liver ab-
scess pus is depicted in the figure. The NM-PCR was 
positive for E. histolytica DNA in all the 28 liver ab-
scess pus specimens (100%) from the ALA patients 
(Table). The test did not detect E. histolytica DNA in 
liver abscess pus from all the 13 patients with PLA. 
DISCUSSION
It is difficult to differentiate clinically the ALA from 
PLA and from other space-occupying lesions of 
the liver, such as hydatid cyst and liver hepatoma 
(27,33). Although the imaging techniques are high-
ly sensitive to detect abscesses in the liver of varied 
aetiology, these fail to distinguish specifically ALA 
from that of PLA. 
The demonstration of E. histolytica trophozoite in 
the liver pus by microscopy confirms the diagno-
sis of ALA, but in best of the conditions, the amoe-
bic trophozoites can be demonstrated in only 15% 
of liver pus (34). Therefore, the laboratory diagno-
sis of ALA is usually established by antibody-based 
serological tests, but the serum antibody levels in 
individuals living in endemic areas continue to 
remain positive even for years after eradication of 
infection with E. histolytica (35-37). A monoclo-
nal antibody-based second-generation TechLab 
E. histolytica II ELISA has been reported to be 78% 
and 40.7% sensitive for the detection of E. histolyti-
ca Gal/GalNAc lectin antigen in the serum and liver 
pus of ALA patients respectively (28). 
Earlier, the PCR to detect Entamoeba DNA in stool 
samples has been evaluated as a sensitive and spe-
cific method for the diagnosis of intestinal amoe-
biasis (38-46). Studies conducted in various labora-
tories worldwide have shown that PCR has a varied 
T
a
b
l
e
.
 
D
e
t
e
c
t
i
o
n
 
o
f
 
E
n
t
a
m
o
e
b
a
 
D
N
A
 
i
n
 
s
a
l
i
v
a
 
a
n
d
 
l
i
v
e
r
 
a
b
s
c
e
s
s
 
p
u
s
 
s
p
e
c
i
m
e
n
s
 
o
f
 
A
L
A
 
p
a
t
i
e
n
t
s
 
b
y
 
a
p
p
l
y
i
n
g
 
1
6
S
-
l
i
k
e
 
r
R
N
A
 
g
e
n
e
-
b
a
s
e
d
 
n
e
s
t
e
d
 
m
u
l
t
i
p
l
e
x
 
P
C
R
D
i
a
g
n
o
s
i
s
N
o
.
 
o
f
p
a
t
i
e
n
t
s
N
o
.
 
(
%
)
 
o
f
 
p
o
s
i
t
i
v
e
 
r
e
s
u
l
t
s
 
b
y
1
6
S
-
l
i
k
e
 
r
R
N
A
 
g
e
n
e
-
b
a
s
e
d
 
n
e
s
t
e
d
 
m
u
l
t
i
p
l
e
x
 
P
C
R
 
f
o
r
S
a
l
i
v
a
 
s
p
e
c
i
m
e
n
s
L
i
v
e
r
 
a
b
s
c
e
s
s
 
p
u
s
 
s
p
e
c
i
m
e
n
s
E
.
 
h
i
s
t
o
l
y
t
i
c
a
E
.
 
d
i
s
p
a
r
E
.
 
m
o
s
h
k
o
v
s
k
i
i
E
.
 
h
i
s
t
o
l
y
t
i
c
a
E
.
 
d
i
s
p
a
r
E
.
 
m
o
s
h
k
o
v
s
k
i
i
A
m
o
e
b
i
c
 
l
i
v
e
r
 
a
b
s
c
e
s
s
2
8
8
 
(
2
8
.
6
)
0
0
2
8
 
(
1
0
0
)
0
0
P
y
o
g
e
n
i
c
 
l
i
v
e
r
 
a
b
s
c
e
s
s
1
3
0
0
0
0
0
0
O
t
h
e
r
 
d
i
s
e
a
s
e
s
 
o
f
 
l
i
v
e
r
8
0
0
0
N
A
N
A
N
A
 
H
e
a
l
t
h
y
 
c
o
n
t
r
o
l
s
3
5
0
0
0
N
A
N
A
N
A
N
A
=
N
o
t
 
a
p
p
l
i
c
a
b
l
eKhairnar K et al. Detection of salivary Entamoeba histolytica DNA
Volume 26 | Number 4 | December 2008 423
sensitivity ranging from 33% to 100% for detect-
ing E. histolytica DNA in liver abscess pus for the 
diagnosis of ALA (28,32,47-49). Recently, we have 
reported, for the first time, the excretion of E. his-
tolytica DNA in the urine of ALA patients by apply-
ing PCR (32).
Like urine, saliva is also an easily-accessible and 
non-invasive body-fluid. Detection of salivary anti-
gen has been studied earlier for the diagnosis of a 
few viral infections, such as Epstein-Barr virus and 
hepatitis B virus (17,50). There is only one report 
on the detection of E. histolytica Gal/GalNAc lectin 
antigen in the saliva of ALA patients (21). Although 
reports are available for the detection of salivary 
DNA by PCR for the diagnosis of Epstein-Barr virus, 
cytomegalovirus, human herpes virus 6, 7, and 8, 
rabies virus, and H. pylori (22-26), till now, to the 
best of our knowledge, there is no report available 
on the detection of E. histolytica DNA in saliva. 
In the present study, an attempt was made, for the 
first time, to detect Entamoeba DNA in saliva of ALA 
patients by applying NM-PCR. The NM-PCR in the 
study detected E. histolytica DNA in eight (28.6%) 
of the 28 saliva specimens collected from the ALA 
patients (Table). The assay detected E. histolytica 
DNA in saliva of eight of the 20 cases with ALA, 
who were already treated with metronidazole. The 
PCR did not detect E. histolytica DNA in saliva of the 
remaining eight cases of ALA, who were not treated 
with metronidazole. This might be due to the re-
lease of E. histolytica DNA from the dying E. histolyt-
ica trophozoites when metronidazole therapy was 
initiated, which might have led to the release of E. 
histolytica DNA in the saliva of ALA patients.
The sensitivity of NM-PCR to detect E. histolytica 
DNA in the saliva was 28.6%. This was found to 
be significantly lower than the sensitivity of NM-
PCR to detect E. histolytica DNA in the liver ab-
scess pus (100%), using McNemar’s chi-square test 
(p<0.0001).
The NM-PCR was negative for E. histolytica DNA in 
the saliva of all the 21 patients with PLA and other 
diseases of the liver, and 35 healthy controls. This 
represents a specificity of 100% (Table). In the pres-
ent study, none of the saliva and liver abscess pus 
specimens was positive for either E. dispar or E. 
moshkovskii by the NM-PCR, which confirms the 
non-invasive nature of these non-pathogenic spe-
cies (Table).
The present study, for the first time, demonstrates 
the release of E. histolytica DNA in the saliva speci-
mens of ALA patients by applying NM-PCR. 
However, as a diagnostic tool, the limitation of NM-
PCR was that it could only detect E. histolytica DNA 
in the saliva specimens of ALA patients who had 
already received treatment with metronidazole 
with a sensitivity of only 40% but could not detect 
E. histolytica DNA in the saliva specimens of un-
treated ALA patients. Therefore, the present study 
on the detection of E. histolytica DNA in the saliva 
of ALA patients may not be used as a diagnostic 
tool. Nevertheless, the saliva as a clinical specimen 
offers distinctive advantage over blood as a diagnos-
tic fluid. The first and foremost advantage is that it 
can be collected non-invasively by individuals with 
minimum training. Second, the use of saliva as a 
clinical specimen may prove to be a cost-effective 
approach for the screening of a large number of pa-
tients, especially in epidemiological studies. Finally, 
saliva has the potential to be used for the diagnosis 
of invasive infectious diseases because it is collected 
readily and is also known to contain serum constit-
uents. The serum constituents present in saliva are 
derived from the salivary gland’s local vasculature 
which ultimately reaches the oral cavity through 
the flow of gingival fluid (51). However, we feel that 
additional studies are needed in the field before the 
true clinical and diagnostic value of saliva as a clini-
cal specimen can be established.
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